Neuropharmacology Conferences | CME Conferences | Neurochemistry Conferences | Neurology Conferences | Europe Meetings | Paris Conferences| Asia Events | USA | Middle East| 2018

Theme: Neuropharmacology: Major Challenges and Breakthroughs

Neuropharmacology 2018

Scientific Program-2018

Renowned Speakers

Hari Shanker Sharma
Uppsala University
Sweden

Stephen D Skaper
University of Padua
Italy

David Truswell
Somefreshthinking Consultancy
UK

Varghese John
University of California
USA

Alireza Rezayi
Shahid Beheshti University of Medical Sciences
Iran

Harish C Pant
National Institutes of Health
USA

Eunji Cheong
Yonsei University
South Korea

Mariya Hristova
University College London
UK

Joel B Schachter
Merck Research Laboratories
USA

Ying-Chieh Tsai
National Yang-Ming University
Taiwan

Michael V Ugrumov
Institute of Developmental Biology RAS
Russia

Istvan Berczi
University of Manitoba
Canada

Ni Hong
Soochow University
China

M Cohen-Armon
Tel-Aviv University
Israel

Yacov RofÃ©
Bar-Ilan University
Israel

Arieh S Solomon
Tel Aviv University
Israel

Young-Ho Lee
Hanyang University College of Medicine
South Korea

Hyo Joon Kim
Presbyterian Medical Center
South Korea

Hua P Su
MSD Research Labs
USA

Jan Ulfberg
Capio Sleep Center
Sweden

Maha Nada
Ain Shams University
Egypt

Saule T Turuspekova
KazNMU
Kazakhstan

Jiangang Shen
The University of Hong Kong
China

Elizabeth K Barber
Barber Innovations LLC
USA

Michel CYR
University of Trois-Rivieres
Canada

Oscar Bernal-Pacheco
Instituto Roosevelt
Canada

Anita N Datta
University of British Columbia
Canada

Kay Chang
University of Macau
China

Hala Fakhiry
Cairo University
Egypt

Giuseppe Scalabrino
University of Milan
Italy

Donard S Dwyer
LSU Health Sciences Center
USA

Kjell Fuxe
Karolinska Institutet
Sweden

Keith Pennypacker
University of Kentucky
USA

Georgianna G Gould
The University of Texas
USA

Hua Su
University of California
USA

Kailash N Pandey
Tulane University
USA

Kazue Takayanagi
Seiwaen Geriatric Institute
Japan

Masaraf Hussain
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
India

Mark W Burke
Howard University
USA

Takashi Kitajima
ONO Pharmaceutical Co., LTD
Japan

Thomas Grund
University of Regensburg
Germany

Hideo Tsukada
Hamamatsu Photonics K.K.
Japan

Maria Lindau
Stockholm University
Sweden

Marina Zueva
Moscow Helmholtz Research Institute of Eye Diseases
Russia

Saobo Lei
University of North Dakota
USA

Patrizia LoPresti
University of Illinois at Chicago
USA

Gjumrakch Aliev
GALLY International Biomedical Research Institute Inc.
USA

Nachum Dafny
The University of Texas
USA

Rameshwar K Sharma
Salus University
USA

Clint L Makino
Boston University
USA

Teresa Duda
Salus University
USA

James B Ames
University of California
USA

Saravanan Kolandaivelu
West Virginia University Eye Institute
USA

Thomas Rich
University of South Alabama
USA

Boris Tchernychev
Ironwood Pharmaceuticals Inc.
USA

Elangovan Vellaichamy
University of Madras
India

Ana MÃ©ndez
University of Barcelona
Spain

Ichiro N Maruyama
Okinawa Institute of Science and Technology
Japan

Frans Vinberg
Washington University School of Medicine
USA

Magnus S Magnusson
University of Iceland
Iceland

Nicolas Marie
Neuroplasticity and Therapies of Addictions
France

Jose F Abisambra
University of Kentucky
USA

Cristina Vittoria Dieni
University of Perugia
Italy

JosÃ© R Sotelo
Instituto de Investigaciones BiolÃ³gicas Clemente Estable
USA

Xavier F Figueroa
Pontificia Universidad Catolica de Chile
Chile

Anna PuigdellÃvol-SÃ¡nchez
University of Barcelona
Spain

Stephanie C Joachim
University Eye Hospital
Germany

Enzo Wanke
University of Milano-Bicocca
Italy

Ahmed K Salama
Majmaah University
Saudi Arabia

Hari S Sharma
Uppsala University,Sweden
Sweden

Mehrdad Shamloo
Stanford University,USA
USA

Wilfried Dimpfel
Justus Liebig University Giessen, Germany
Germany

Olga Malyshevskaya
Tsukuba University, Japan
Japan

Eva Kudova
Institute of Organic Chemistry and Biochemistry â€“ ASCR, Czech Republic
Czech Republic

Aruna Sharma
Uppsala University,Sweden
Sweden

Neuropharmacology 2018

Welcome Message

Dr. Hari S Sharma

Congress-Chairman

This is my honor and pleasure to invite you all for the 9th Global Experts Meeting on Neuropharmacology in Historic City of German Capital Berlin, Nov 15 and 16, 2018.

”The City of Berlin is known to establish the first concept of the blood-brain barrier (BBB) by Paul Ehrlich in 1885 in Berlin Humboldt University and was followed by his student Edwin Goldman 1887 to confirm the existence of the BBB formerly known as “hematoencephalic barrier”. Still today, the BBB is responsible for all drug targets to develop potential therapeutic strategies to treat brain diseases. Thus, Neuropharmacology 2018 in city of Berlin is in line with this tradition. On his Pioneer work on Physiology & Immunology, Paul Ehrlich was awarded Nobel Prize of Physiology & Medicine in 1908. Berlin has the honor of receiving 7 novel prizes in Physiology and Medicine from 1901 to 1956 namely Emil von Behring (1901), Robert Koch (1905), Paul Ehrlich (1908), Albrecht Kossel (1910), Otto Warburg (1931), Hans Spemann (1935) and Werner Forßmann (1956).

This great tradition of innovation and discovery is still continuing in Berlin. This is evident by several Universities of high repute with research and innovation that are present in the Berlin-Brandenburg region in which about 40 Nobel Laureates in various fields are associated. The notable among are Humboldt University zu Berlin, Free University of Berlin and technical University of Berlin. Berlin is also known for the Internationally renowned Research Institutions of high repute as Independent organization such as the Fraunhofer Society, the Leibniz Association, the Helmholtz Association, and the Max Planck Society.

I am sure that this conference will stimulate research and innovation as leading experts in neuropharmacology are presenting their cutting edge research at this meeting. Be a part of this great scientific extravaganza and the charm of Berlin city to enlighten your mind with new knowledge for the advancement of healthcare fir neurological disease and drug targets.

I hope this 2-days scientific discussion and presentations by leading experts in the World as well as new research carried out by young scientist will provide a perfect amalgam for novel drug discovery in both basic and clinical research. The outcome of the congress will pave ways to new developments for drug therapy and raises hope in the victims of neurological disease Worldwide.

Based on the past 8 congresses the Berlin Meeting of Neurophramacologists across the Globe will further highlight novel drug discovery and opens new avenues for research and innovation for the benefit of the mankind.

Hari S Sharma, Ph. D., Dr. Med. Sci., FAIS (New York), FABRI (N. Carolina)
Director, Int. Expt. CNS Injury & Repair;
Prof. Neurobiology (MRC)
University Hospital, Uppsala University, Sweden

Track 1: Neuroimmunology and Neuroinflammation

It deals with a branch of immunology concerned with the interactions between immunological and nervous system functions also associated autoimmune diseases. Encephalitis is acute inflammation of the brain resulting from a viral infection or an autoimmune disease. Transverse myelitis is a pathogenetically heterogeneous inflammatory disorder in which spinal cord is affected. Huntington disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13^thEuropean Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy

Chinese Medicine, Ayurveda & Acupuncture, March 12-13, 2018 Barcelona, Spain; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 3^rd Conference on Environmental Health & Preventive Medicine, October 15-16, 2018 Warsaw, Poland; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain

Related Societies:

Societies in USA: American Association of Pharmaceutical Scientists, American Association of Pharmacy Technicians, American College of Clinical Pharmacology, American College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 2: Neural Stem Cell

Neural stem cells (NSCs) offer a unique and powerful tool for basic research and regenerative medicine. To date the need to accomplish this has just been met to some degree for neurons got from embryonic undeveloped cells or iPS cells, and still, after all that the information is not of a quality to justify clinical trials. The issue is that, while the cells that can be made in the lab resemble the ones required, they frequently do not have certain fundamental attributes.

7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland

4^th Drug Discovery, Designing & Development, September 06-07, 2018 London, UK; 16^th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 10th Pharmacology, Jul 30-Aug 01, 2018 Barcelona, Spain; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 3: Neuroethics

It includes the social, legal and ethical consequences of advances in neuroscience. It is the amalgamation of neuroscience with ethical thoughts. The ethics of neurocognitive includes brain interventions and imagining, neurological treatments and consciousness disorders.

6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany;12^th Pharmaceutical Sciences and PharmaIndustry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy

10^th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18^th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16^th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 4: Clinical Neuropharmacology

It is the science that studies the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicology, pharmacodynamics and pharmacokinetics. It also includes drug abuse, pain and hypothalamic releasing factors.

4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain

11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16^th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 5: Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioral form. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioral problems. The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany

78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16^th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 6: Neurochemical Transmission

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psychopharmaceuticals, neuropeptides, or gastrotransmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuronal coordination, interaction of drugs and its effect on summation and cotransmission process and advances in astrocyte-neuron interactions in health. Astrocyte dysfunction results into neurodegenerative diseases, stroke, epilepsy, migraine and neuroinflammatory diseases.

13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain

16^th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 7: Behavioral and Addiction Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, anxiety and autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK

18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16^th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 8: Neurotechnology

It is the measurement and analysis of chemical and electrical signals of nervous system. It includes neurocircuitary analysis, novel trans-synaptic tracing approaches, advancements of optical techniques, neuromodulation and transcranial magnetic stimulation. Neurotechnology plays a crucial role in diagnostics and identification of nervous activities.

9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK

6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 9: Neuroendocrinology

It is the study of interactions between the nervous system and the endocrine system, also biological features of the cells involved and their communications. Most Important aspects of neuroendocrinology are insulin receptor and hypothalamic programming; stress, coping and interactions, neuro-endocrine-immune symphony, pituitary structure and hormone secretion.

12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany

6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 16th Pharmaceutical Formulations July 26-27, 2018 Rome, Italy; 18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 10: Alzheimer's Disease and Dementia

Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and become severe enough to interfere with daily tasks. Amyloid plaques are also found in the brain of Alzheimer patients. Neurocognitive effects associated with therapeutic drugs and animal cognition and behaviour - Fear and aversive learning and memory.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy

78^th Congress on Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations July 26-27, 2018 Rome, Italy

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 11: Parkinson disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. Associated effects are anxiety; depression, stress, ageing and neurodegenerative disorders, disease diagnostics, drug designing and therapeutics are the research areas.

7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland

16th Pharmaceutical Formulations July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK;; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain;

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 12: Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits. The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of psychiatric and neurodegenerative diseases. It infers that brain diseases are resulted from disruption of synaptic structure and function.

6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy

18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 13: Future Aspects of Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapy, immunoglobulin therapy, gene therapy in neuronal disorders and neural engineering.

4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7^th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12^th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10^th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain

10th Pharmacology, Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78^th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK

Related Societies:

Societies in Asia: The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

ConferenceSeries Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth "9^th Global Experts Meeting on Neuropharmacology” (Neuropharmacology 2018) scheduled to be held during November 15-16, 2018 at Berlin, Germany. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacologyand Neuropharmacology.

ConferenceSeries Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access Journals which contains over 70000 eminent personalities as editorial board members as reputed scientists and 1200+ Symposiums & Workshops. To know more about the conference series

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.

Target Audience:

Neuropharmacology Students, Scientists
Neuropharmacology Researchers
Neuropharmacology Faculty
Medical Colleges
Neuropharmacology Associations and Societies
Business Entrepreneurs
Training Institutes
Software developing companies
Manufacturing Medical Devices Companies
Data Management Companies

2018 Highlights:

300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
20+ Exhibitors
14 Innovative Educational Sessions
5+ Workshops
B2B Meetings

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Neuropharmacology 2017 Conference the best ever!

The 7 ^th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series was held during July 31- August 02, 2017 at Hilton Garden Inn Milan North, Milan, Italy based on the theme “Neuropharmacology: Major Challenges and Breakthroughs". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

Know more at Neuropharmacology 2017 Proceedings

Conference Series expresses its gratitude to the conference Moderators, namely Dr. Jong Eun Lee, Dr. Mariya Hristova and Dr. Maha Nada for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Hari Shanker Sharma, Uppsala University, Sweden
Stephen D Skaper, University of Padua, Italy
David Truswell, Somefreshthinking Consultancy, UK
Michael V Ugrumov, Institute of Developmental Biology RAS, Russia
Ni Hong, Soochow University, China
M Cohen-Armon, Tel-Aviv University, Israel
Istvan Berczi, University of Manitoba, Canada

We are grateful to our Spekaers of Special session. The list comprises:

Harish C Pant, National Institutes of Health, USA
Yacov Rofé, Bar-Ilan University, Israel

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Neuro Immune Pharmacology
Molecular Neuropharmacology
Psychopharmacology
Neurochemical Transmission
Behavioral Neuropharmacology
Neurotechnology
Neuroendocrinology
Alzheimer’s Disease and Dementia
Parkinson’s Disease
Neuroethics
Future Aspects of Neuropharmacology
Clinical Neuropharmacology
Chemical Neurotransmitters
Case Study Reports
Entrepreneurs Investment Meet

Conference Series offers its heartfelt appreciation to organizations such as Bentham Science and our esteemed supporters SelectScience Trade Show Alerts Medgenera CrowdReviews PBR Clinical Biometrics Bio-Equip Nanobay Pharma Focus Asia ManuscriptEdit Times International eindiabusiness and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conference Series also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2017, Conference Series is proud to announce the " 9^th Global Experts Meeting on Neuropharmacology" to be held during November 15-16, 2018 at Berlin, Germany

Summary: Neuropharmacology 2018 welcomes attendees, presenters, and exhibitors from all over the world to Berlin, Germany. We are delighted to invite you all to attend and register for the “9th Global Experts Meeting on Neuropharmacology (Neuropharmacology 2018)” which is going to be held during November 15-16, 2018 Berlin,Germany. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuropharmacology-2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Neuropharmacology 2018 organizing committee look forward to meet you at Berlin,Germany.

For more details please visit http://neuro.pharmaceuticalconferences.com/

Importance and Scope: Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

Comparative analysis for Neurological Disorders (Age wise profile)

Conference Highlights

Neuroimmunology and Neuroinflammation
Neural Stem Cell
Molecular Neuropharmacology
Clinical Neuropharmacology
Psychopharmacology
Neurochemical Transmission
Behavioral and Addiction Neuropharmacology
Neurotechnology
Neuroendocrinology
Alzheimer’s Disease and Dementia
Parkinson’s Disease
Neuroethics
Future Aspects of Neuropharmacology
Case Study Reports

Attendance Profile according to specialization in a Neuroscience Conference

Hospitals of Neuropharmacology

Top Hospitals

Mayo Clinic, Rochester, Minnesota
Johns Hopkins Hospital, Baltimore, Maryland
Massachusetts General Hospital, Boston
University of California–San Francisco Medical Center
Mathodist Hospital, San Antonio
University of California–Los Angeles Medical Center
New York University Langone Medical Center, New York City
Hospitals of the University of Pennsylvania–Penn Presbyterian
Northwestern Memorial Hospital, Chicago
Baptist Medical Centre, San Antonio

Major Neuropharmacology related Associations around the Globe

Canadian Neurological Sciences Federation
European Parkinson’s disease Association
Malaysian Society of Neurosciences
Eurospine, The Spine Society Of Europe
The Spanish Society of Neurology (SEN)
The Czech Neuropsychopharmacological Society
Belgian Neurological Society
National Neurotrauma Society
National Parkinson'S Foundation
European Society Of Neurosonology And Cerebral Hemodynamics
Federation Of European Neuroscience Societies
Malaysian Society Of Neurosciences
ÄŒeská Neurologická SpoleÄnost
The Czech Neuropsychopharmacological Society
European Academy Of Neurology
Deutsche Gesellschaft Fur Neurologieologie
International Brain Research Organization
The Neuropathy Association
The Primary Care Neurology Society
The Spanish Society Of Neurology (SEN)

Major Neuropharmacology related Associations

International Neuroethics Society
Society for Behavioral Neuroendocrinology
Society For Neuroscience
American Psychological Association
International Parkinson and Movement Disorder Society
American Neurological Association
National Institute Of Environmental Health Sciences
The American Society of Neuroimaging
American Board Of Psychiatry And Neurology, Inc.
American Clinical Neurophysiology Society
International Neuropsychological Society
Southern Clinical Neurological Society
International Parkinson And Movement Disorder Society

Products for Neurological Treatments

This above statistic displays the global revenue of Abilify from Bristol-Myers Squibb from 2011 to 2014. In the United States alone, Abilify generated a revenue of 2.1 million U.S. dollars in 2012. Abilify is an antipsychotic agent that is used to treat various conditions such as schizophrenia, bipolar mania disorder, and major depressive disorder.

Gross Profit Margin of Neuropharmaceutical related companies

Market Capitalization of Neuropharmaceutical companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Sales Profile of Neuropharmaceutical companies

Research Fund: NIH (National Institute of Health) and NSFC (Nature Science Foundation of China) provided fund for the neurological disorders such as dementia, schizophrenia, stroke, parkinson’s, epilepsy.

Institutes funding for research

The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universitat Pompeu Fabra, Barcelona
Neuropharmacology Program, The National Institute of Mental Health (NIMH)
McKnight Endowment Fund for Neuroscience

The statistic depicts the research and development expenditure of the entire pharmaceutical industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

Global Top Environment Universities

USA Evirnonment Universities

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 15-16, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View